Both in Pharmaceuticals
PERRIGO vs Trevi Therapeutics
Over the past year PRGO returned −31.0% and TRVI returned +61.1%; their daily moves had a correlation of 0.10.
PRGO −31.0% TRVI +61.1%Growth of $1, one year, split-adjusted
| Metric | PRGO | TRVI |
|---|---|---|
| Price | $15.00 | $14.42 |
| Market cap | $2.08B | $2.05B |
| Today | −0.66% | +0.14% |
| 1 month | +3.6% | −14.1% |
| 6 months | +54.3% | +28.9% |
| Year to date | +7.8% | +15.2% |
| 1 year | −30.1% | +64.4% |
| Revenue growth (YoY) | −3.2% | — |
| Gross margin | 30.7% | — |
| Net margin | 7.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | — |
| Net cash | -$2.90B | $318.9M |
| Dividend yield | 7.73% | — |
| Volatility (60d) | 62.6% | 59.0% |
| Short % of float | 16.4% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).